Merck to Showcase Advances in the Science of Cancer With New Data Presented at ASCO 2024 itnewsonline.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from itnewsonline.com Daily Mail and Mail on Sunday newspapers.
First-in-human data for potential first-in-class anti-CEACAM5 ADC with topoisomerase 1 inhibitor payload, M9140, in treatment of metastatic colorectal cancer to be featured in oral presentation
Merck a leading science and technology company today announced that 43 abstracts covering several modalities and mechanisms will be presented at the 2023 American Society of Clinical Oncology ASCO Annual Meeting June 26 Chicago Ill. US.
EMD Serono Highlights Commitment to Improving Cancer Outcomes at ASCO 2023 streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.
Not intended for UK-, US- or Canada-based media Merck, a leading science and technology company, today announced that 43 abstracts covering several modalities and mechanisms will be presented at the